R5P (Riboflavin-5-Phosphate)
Last reviewed
R5P is the activated form of vitamin B2 that bypasses the conversion step plain riboflavin requires. Around 85% of hEDS patients carry MTHFR variants where R5P is the cofactor needed for proper methylation. Riboflavin also has strong evidence in migraine prophylaxis, relevant for the 65% of POTS patients who get migraines. ZebraThrive uses 25 mg AM.
At a Glance
Daily Dose
25 mg AM
Key Benefits
How It Works
R5P is the activated form of vitamin B2 (riboflavin) - your body normally has to convert plain riboflavin into R5P before it can do its work as a cofactor. For people with MTHFR polymorphisms (around 85% of hEDS patients carry at least one variant), R5P is especially important because it's the cofactor MTHFR needs to do methylation properly. Riboflavin has decades of clinical evidence in migraine prophylaxis (relevant because around 65% of POTS patients also have migraines) and supports mitochondrial energy production through the electron transport chain. We use the activated form because the conversion step can be impaired.
What the Research Shows
Riboflavin (as FAD) is the cofactor for MTHFR. In people with MTHFR C677T variants (around 85% of hEDS patients carry at least one copy), the enzyme is less stable and more dependent on riboflavin availability. RCT evidence in TT-homozygous adults shows targeted riboflavin supplementation produces clinically meaningful blood-pressure improvements, confirming the genotype-cofactor interaction.
Cross-sectional dietary intake analysis stratified by MTHFR C677T genotype
Higher riboflavin intake associated with significantly lower SBP in TT-genotype adults; effect not observed in CC/CT genotypes (cofactor-dependent interaction)
Cross-sectional, 242 adults stratified by genotype
TT homozygotes had SBP ~5.5 mmHg higher than CC counterparts despite similar nutrient intakes; cofactor inadequacy is mechanism
Narrative + targeted review
Summarises RCT evidence that riboflavin supplementation in TT homozygotes reduces SBP by 5-13 mmHg; identifies riboflavin as a modifiable factor for the most common genetic cause of hypertension
Riboflavin has decades of clinical evidence in migraine prophylaxis at the reference dose of 400 mg/day; meta-analytic evidence supports a meaningful reduction in monthly headache days. Our 25 mg dose is well below the migraine-prophylactic range and is positioned as foundational methylation support, not migraine treatment.
Systematic review + meta-analysis of 9 studies, 673 subjects, riboflavin 400 mg/day
Riboflavin supplementation reduced monthly migraine days and frequency vs placebo; effect size consistent across studies
Evidence-graded clinical practice guideline
Riboflavin given a strong recommendation for migraine prophylaxis based on consistent RCT evidence
Randomized, placebo-controlled trial in episodic migraine
Comparator trial confirming riboflavin as established migraine prophylactic; situates B2 within the mitochondrial-energy class of preventives
Riboflavin is the precursor to FAD and FMN, the cofactors for Complex I and Complex II of the electron transport chain and the FAD-dependent flavoproteins of fatty acid beta-oxidation. The mitochondrial mechanism is why riboflavin works for migraine and is mechanistically relevant to the deep fatigue many POTS and hEDS patients experience.
RCT placing riboflavin alongside CoQ10 in the mitochondrial-energy class
Establishes mitochondrial energy support (riboflavin -> FAD/FMN -> Complex I/II) as the mechanistic class for migraine prophylaxis and post-exertional fatigue
Addressing the Triad
Tailored benefits for complex conditions
R5P doesn't directly engage mast cells - it's a vitamin B2 cofactor. The MCAS-relevant role is indirect and important: methylation. Your body breaks down histamine through HNMT (histamine N-methyltransferase), which needs methyl groups from SAMe, which needs the methyl-folate cycle, which needs MTHFR, which needs R5P. So R5P keeps the histamine clearance pathway functional from the back end. For MCAS patients with MTHFR variants - and most have them - R5P is part of why the methylation support stack (methylfolate, methylated B12, R5P) actually works together. Foundational, not a hero ingredient.
For hEDS, R5P contributes on two layers. First, mitochondrial energy: riboflavin is the precursor to FAD and FMN, the cofactors for Complex I and Complex II of the electron transport chain. Fibroblasts with mitochondrial dysfunction upregulate MMP-1 (the matrix-degrading enzyme), and supporting energy production at the cellular level helps keep that pathway quieter. Second, methylation: 85% of hEDS patients carry MTHFR variants, and R5P is the cofactor MTHFR needs to do its job. Better methylation supports the whole downstream pathway - neurotransmitters, histamine, homocysteine handling, methyl group availability.
For POTS, R5P contributes on two layers: mitochondrial energy support for the deep fatigue that frequently shadows POTS (many patients also meet ME/CFS criteria), and methylation support that matters for catecholamine breakdown through COMT. Our 25 mg dose is well below the 400 mg used in migraine prophylaxis trials but provides daily baseline coverage relevant to the migraine-POTS overlap. Foundational rather than a primary intervention.
Why We Chose This Form
We use riboflavin-5-phosphate (R5P) - the activated form your enzymes can use directly. Plain riboflavin needs to be converted by riboflavin kinase in your liver before it becomes biologically active, and that conversion step can be impaired in people with chronic illness, inflammation, or methylation pathway dysfunction. Using R5P directly bypasses the conversion bottleneck. The dose is 25 mg - well above the basic vitamin requirement but conservative compared to the 400 mg used in migraine prophylaxis trials. It's an MTHFR-friendly dose for daily methylation support without crossing into therapeutic migraine territory.
Safety & Interactions
Potential Side Effects
Excellent safety profile. May cause harmless bright yellow urine color (excreted excess riboflavin). No clinically meaningful adverse events at the 25 mg dose; trial doses up to 400 mg/day for migraine prophylaxis have been used safely for 3+ months.
Drug Interactions
Methotrexate users should mention any methylated B-vitamin stack to their prescriber, as methylated cofactors can affect methotrexate's antifolate mechanism. Some antiepileptics (phenobarbital, carbamazepine) and tetracycline antibiotics can interact with riboflavin metabolism; mention to your prescriber if you are on any of those. Otherwise, R5P has one of the cleaner interaction profiles among B vitamins.
Excipients to Avoid
- Fermentation-derived sources
- Artificial colors
- Magnesium stearate
Safe Excipients
- HPMC capsules
- Rice flour
- Cellulose
- [1]Effects of vitamin B2 supplementation in adults with migraine: a systematic review and meta-analysisPMID: 33779525
Chen YS et al. (2021)
- [2]Higher levels of dietary B vitamins are associated with better blood pressure in homozygous MTHFR 677TT adultsPMID: 32330571
Rooney M et al. (2020)
- [3]Impact of the MTHFR C677T polymorphism on blood pressure phenotype: results from the JINGO projectPMID: 35821207
Rooney M et al. (2022)
- [4]Riboflavin status, MTHFR genotype and blood pressurePMID: 27170501
McAuley E et al. (2016)
- [5]Canadian Headache Society guideline for migraine prophylaxisPMID: 22683887
Pringsheim T et al. (2012)
- [6]Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trialPMID: 15728298
Sandor PS et al. (2005)
Common Questions
Written by Ken Chapman, Founder of ZebraThrive. Reviewed and last updated .